Literature DB >> 17444428

Hepatitis-C prevalence in an urban native-American clinic: a prospective screening study.

Amy S Neumeister1, LaVada E Pilcher, Judi M Erickson, Lora L Langley, Mary M Murphy, Nicole M Haukaas, Mark E Mailliard, Jennifer L Larsen.   

Abstract

BACKGROUND: Native-American populations are disproportionately burdened by chronic liver disease, and the prevalence of hepatitis C (HCV) in native Americans is unknown.
PURPOSE: To determine the prevalence of hepatitis C in a local native-American population via a prospective screening study. PROCEDURES: Two-hundred-forty-three native Americans (161 females/82 males) using an urban clinic and representing > 30 tribes from across the United States were screened. Mean age was 41 +/- 1 years. Hepatitis-C screening was by anti-HCV with confirmation by HCV RNA. A questionnaire assessed potential risk factors for HCV.
FINDINGS: Anti-HCV antibodies were found in 11.5% (95% CI: 7.5-15.5%). HCV RNA was present by polymerase chain reaction (PCR) in 8.6% (95% CI: 5.1-12.1%) and was more common in males [13.4% (95% CI: 6.0-20.8%)] than females [6.2% (95% CI: 2.5-9.9%)]. The most common potential risk factors for chronic HCV infection were intravenous (IV) drug or cocaine use (p < 0.0001), tattoos > 5 years old (p < 0.0001) and having a sexual partner with HCV (p = 0.0063).
CONCLUSION: HCV prevalence is higher in an urban native-American clinic population than reported in the general U.S. population. Use of IV drugs is the most prevalent risk factor, but tattoos and sexual transmission may also be important.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17444428      PMCID: PMC2569647     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  13 in total

1.  Epidemiology of hepatitis C in the United States.

Authors:  I Williams
Journal:  Am J Med       Date:  1999-12-27       Impact factor: 4.965

2.  Elevated prevalence of hepatitis C infection in users of United States veterans medical centers.

Authors:  Jason A Dominitz; Edward J Boyko; Thomas D Koepsell; Patrick J Heagerty; Charles Maynard; Jennifer L Sporleder; Andrew Stenhouse; Mitchel A Kling; William Hrushesky; Charles Zeilman; Stephen Sontag; Nikunj Shah; Fernando Ona; Bhupinder Anand; Marc Subik; Thomas F Imperiale; Samer Nakhle; Sam B Ho; Edmund J Bini; Bruce Lockhart; Jawad Ahmad; Anna Sasaki; Brian van der Linden; Doris Toro; Jaime Martinez-Souss; Vivek Huilgol; Seth Eisen; Keith A Young
Journal:  Hepatology       Date:  2005-01       Impact factor: 17.425

3.  The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.

Authors:  M J Alter; D Kruszon-Moran; O V Nainan; G M McQuillan; F Gao; L A Moyer; R A Kaslow; H S Margolis
Journal:  N Engl J Med       Date:  1999-08-19       Impact factor: 91.245

Review 4.  The burden of hepatitis C in the United States.

Authors:  W Ray Kim
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

Review 5.  Epidemiology of hepatitis C.

Authors:  M J Alter
Journal:  Hepatology       Date:  1997-09       Impact factor: 17.425

6.  Detecting alcoholism. The CAGE questionnaire.

Authors:  J A Ewing
Journal:  JAMA       Date:  1984-10-12       Impact factor: 56.272

7.  An outbreak of hepatitis C virus infections among outpatients at a hematology/oncology clinic.

Authors:  Alexandre Macedo de Oliveira; Kathryn L White; Dennis P Leschinsky; Brady D Beecham; Tara M Vogt; Ronald L Moolenaar; Joseph F Perz; Thomas J Safranek
Journal:  Ann Intern Med       Date:  2005-06-07       Impact factor: 25.391

8.  Hepatitis C infection and type 2 diabetes in American-Indian women.

Authors:  Charlton Wilson
Journal:  Diabetes Care       Date:  2004-09       Impact factor: 19.112

9.  Epidemiology and risk factors for hepatitis C in Alaska Natives.

Authors:  Brian J McMahon; Thomas W Hennessy; Carol Christensen; Dana Bruden; Daniel G Sullivan; Chriss Homan; Heike Deubner; Michael G Bruce; Stephen Livingston; James Williams; David R Gretch
Journal:  Hepatology       Date:  2004-02       Impact factor: 17.425

10.  Lack of evidence of sexual transmission of hepatitis C among monogamous couples: results of a 10-year prospective follow-up study.

Authors:  Carmen Vandelli; Francesco Renzo; Luisa Romanò; Sergio Tisminetzky; Marisa De Palma; Tommaso Stroffolini; Ezio Ventura; Alessandro Zanetti
Journal:  Am J Gastroenterol       Date:  2004-05       Impact factor: 10.864

View more
  10 in total

1.  Prevalence of HCV infection among clients in community-based health settings in Hawaii, 2002-2010: assessing risk factors.

Authors:  Jeremy C Porter; Heather M Lusk; Alan R Katz
Journal:  Am J Public Health       Date:  2013-09-12       Impact factor: 9.308

2.  Toward a more accurate estimate of the prevalence of hepatitis C in the United States.

Authors:  Brian R Edlin; Benjamin J Eckhardt; Marla A Shu; Scott D Holmberg; Tracy Swan
Journal:  Hepatology       Date:  2015-08-25       Impact factor: 17.425

3.  Mortality caused by chronic liver disease among American Indians and Alaska Natives in the United States, 1999-2009.

Authors:  Anil Suryaprasad; Kathy K Byrd; John T Redd; David G Perdue; M Michele Manos; Brian J McMahon
Journal:  Am J Public Health       Date:  2014-04-22       Impact factor: 9.308

Review 4.  The impact of ethnicity on hepatitis C virus treatment decisions and outcomes.

Authors:  Mauricio Lisker-Melman; José L Walewski
Journal:  Dig Dis Sci       Date:  2012-10-12       Impact factor: 3.199

Review 5.  Chronic liver disease in Aboriginal North Americans.

Authors:  John D Scott; Naomi Garland
Journal:  World J Gastroenterol       Date:  2008-08-07       Impact factor: 5.742

6.  Hepatitis C Virus Infection in Indigenous Populations in the United States and Canada.

Authors:  Veronica Bruce; Jonathan Eldredge; Yuridia Leyva; Jorge Mera; Kevin English; Kimberly Page
Journal:  Epidemiol Rev       Date:  2019-01-31       Impact factor: 6.222

7.  Retrospective Study Demonstrating High Rates of Sustained Virologic Response After Treatment With Direct-Acting Antivirals Among American Indian/Alaskan Natives.

Authors:  Jorge Mera; Kartik Joshi; Karla Thornton; Terry Box; John Scott; Miranda Sedillo; Paulina Deming; Crystal David; Whitney Essex; Richard Manch; Anita Kohli
Journal:  Open Forum Infect Dis       Date:  2019-07-04       Impact factor: 3.835

8.  Meta-analysis: risk of hepatitis C virus infection associated with hospital-based invasive procedures.

Authors:  Paul Henriot; Mathieu Castry; Liem Binh Luong Nguyen; Yusuke Shimakawa; Kévin Jean; Laura Temime
Journal:  Aliment Pharmacol Ther       Date:  2022-06-27       Impact factor: 9.524

Review 9.  Hepatitis C virus in American Indian/Alaskan Native and Aboriginal peoples of North America.

Authors:  Julia D Rempel; Julia Uhanova
Journal:  Viruses       Date:  2012-12       Impact factor: 5.048

10.  Seroprevalence of Hepatitis B and C Infections among Healthy Volunteer Blood Donors in the Central California Valley.

Authors:  Muhammad Y Sheikh; Pradeep R Atla; Adnan Ameer; Humaira Sadiq; Patrick C Sadler
Journal:  Gut Liver       Date:  2012-12-14       Impact factor: 4.519

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.